{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:23:44Z","timestamp":1788175424905,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T00:00:00Z","timestamp":1627430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ejps.2021.105961","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T23:02:54Z","timestamp":1628377374000},"page":"105961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The inhibitors of KDM4 and KDM6 histone lysine demethylases enhance the anti-growth effects of erlotinib and HS-173 in head and neck cancer cells"],"prefix":"10.1016","volume":"166","author":[{"given":"Robert","family":"Kleszcz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Skalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violetta","family":"Krajka-Ku\u017aniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Paluszczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2021.105961_bib0001","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4172\/2155-9872.1000249","article-title":"Three-Dimensional (3D) Cell Cultures in Cell-based Assays for in-vitro Evaluation of Anticancer Drugs","volume":"6","author":"Adcock","year":"2015","journal-title":"J. Anal. Bioanal. Tech."},{"key":"10.1016\/j.ejps.2021.105961_bib0002","doi-asserted-by":"crossref","first-page":"73372","DOI":"10.18632\/oncotarget.19637","article-title":"Inhibition of LSD1 epigenetically attenuates oral cancer growth and metastasis","volume":"8","author":"Alsaqer","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejps.2021.105961_bib0003","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0022034518816947","article-title":"Impact of Epigenetic Regulation on Head and Neck Squamous Cell Carcinoma","volume":"98","author":"Bais","year":"2019","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.ejps.2021.105961_bib0004","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1158\/0008-5472.CAN-16-0754","article-title":"Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K(521) Polymorphism","volume":"77","author":"Braig","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2021.105961_bib0005","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejps.2021.105961_bib0006","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2021.105961_bib0007","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12935-020-01297-6","article-title":"GSK-J4 induces cell cycle arrest and apoptosis via ER stress and the synergism between GSK-J4 and decitabine in acute myeloid leukemia KG-1a cells","volume":"20","author":"Chu","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejps.2021.105961_bib0008","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1158\/2159-8290.CD-19-0463","article-title":"Histone Lysine Methylation Dynamics Control EGFR DNA Copy-Number Amplification","volume":"10","author":"Clarke","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejps.2021.105961_bib0009","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.chembiol.2015.08.007","article-title":"KDM4\/JMJD2 Histone Demethylase Inhibitors Block Prostate Tumor Growth by Suppressing the Expression of AR and BMYB-Regulated Genes","volume":"22","author":"Duan","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejps.2021.105961_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00508-020-01729-3","article-title":"HS-173, a selective PI3K inhibitor, induces cell death in head and neck squamous cell carcinoma cell lines","volume":"133","author":"Foki","year":"2021","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.ejps.2021.105961_bib0011","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10528-019-09941-1","article-title":"Epigenetic Modifications in Head and Neck Cancer","volume":"58","author":"Ga\u017adzicka","year":"2020","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.ejps.2021.105961_bib0012","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/1078-0432.CCR-13-2235","article-title":"A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors","volume":"20","author":"Gray","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2021.105961_bib0013","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000446117","article-title":"Global Epidemiology of Head and Neck Cancers: A Continuing Challenge","volume":"91","author":"Gupta","year":"2016","journal-title":"Oncology"},{"key":"10.1016\/j.ejps.2021.105961_bib0014","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00784-015-1566-5","article-title":"Erlotinib and gefitinib responsiveness in head and neck cancer cell lines\u2014a comparing analysis with cetuximab","volume":"20","author":"Hartmann","year":"2016","journal-title":"Clin. Oral Investig."},{"key":"10.1016\/j.ejps.2021.105961_bib0015","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","article-title":"A Landscape of Pharmacogenomic Interactions in Cancer","volume":"166","author":"Iorio","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejps.2021.105961_bib0016","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.clim.2017.05.014","article-title":"Inhibition of KDM4A activity as a strategy to suppress interleukin-6 production and attenuate colitis induction","volume":"180","author":"Ishiguro","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejps.2021.105961_bib0017","doi-asserted-by":"crossref","first-page":"80348","DOI":"10.18632\/oncotarget.18302","article-title":"KDM4A as a prognostic marker of oral squamous cell carcinoma: Evidence from tissue microarray studies in a multicenter cohort","volume":"8","author":"Jin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejps.2021.105961_bib0018","first-page":"146","article-title":"About the evaluation of drug combination","volume":"25","author":"Jin","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejps.2021.105961_bib0019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s41199-018-0030-z","article-title":"Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC)","volume":"3","author":"Jung","year":"2018","journal-title":"Cancers Head Neck"},{"key":"10.1016\/j.ejps.2021.105961_bib0020","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/odi.12569","article-title":"Epigenetic gene regulation by histone demethylases: emerging role in oncogenesis and inflammation","volume":"23","author":"Kang","year":"2017","journal-title":"Oral Dis."},{"key":"10.1016\/j.ejps.2021.105961_bib0021","doi-asserted-by":"crossref","first-page":"28965","DOI":"10.18632\/oncotarget.25656","article-title":"EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indication","volume":"9","author":"Khaznadar","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejps.2021.105961_bib0022","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/15592294.2018.1481703","article-title":"Inhibition of the histone demethylase KDM4B leads to activation of KDM1A, attenuates bacterial-induced pro-inflammatory cytokine release, and reduces osteoclastogenesis","volume":"13","author":"Kirkpatrick","year":"2018","journal-title":"Epigenetics"},{"key":"10.1016\/j.ejps.2021.105961_bib0023","first-page":"661","article-title":"The effect of niclosamide on the head and neck carcinoma cells survival and the expression of wnt\/\u03b2-catenin signaling and glycolysis pathway components","volume":"76","author":"Kleszcz","year":"2019","journal-title":"Acta Pol. Pharm. - Drug Res."},{"key":"10.1016\/j.ejps.2021.105961_bib0024","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s13402-019-00440-4","article-title":"Inhibition of CBP\/\u03b2-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells","volume":"42","author":"Kleszcz","year":"2019","journal-title":"Cell. Oncol."},{"key":"10.1016\/j.ejps.2021.105961_bib0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.15761\/OHNS.1000111","article-title":"Differential compensation mechanisms define resistance to PI3K inhibitors in PIK3CA amplified HNSCC","volume":"1","author":"Michmerhuizen","year":"2016","journal-title":"Otorhinolaryngol.-Head Neck Surg."},{"key":"10.1016\/j.ejps.2021.105961_bib0026","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.canlet.2012.08.020","article-title":"HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis","volume":"328","author":"Lee","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejps.2021.105961_bib0027","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1158\/0008-5472.CAN-18-0459","article-title":"BET Inhibition Overcomes Receptor Tyrosine Kinase\u2013Mediated Cetuximab Resistance in HNSCC","volume":"78","author":"Leonard","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2021.105961_bib0028","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00432-018-2631-7","article-title":"Therapeutic potential of GSK-J4, a histone demethylase KDM6B\/JMJD3 inhibitor, for acute myeloid leukemia","volume":"144","author":"Li","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ejps.2021.105961_bib0029","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3389\/fphar.2020.00632","article-title":"Synergy of GSK-J4 With Doxorubicin in KRAS-Mutant Anaplastic Thyroid Cancer","volume":"11","author":"Lin","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105961_bib0030","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.3390\/cancers11111785","article-title":"Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc","volume":"11","author":"Lin","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejps.2021.105961_bib0031","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1002\/jcb.26920","article-title":"EGFR-mediated signaling pathway influences the sensitivity of oral squamous cell carcinoma to JQ1","volume":"119","author":"Liu","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejps.2021.105961_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113729","article-title":"PI3K\/AKT\/mTOR signaling as a molecular target in head and neck cancer","volume":"172","author":"Marquard","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105961_bib0033","doi-asserted-by":"crossref","first-page":"8906","DOI":"10.18632\/oncotarget.2417","article-title":"The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapies","volume":"5","author":"Martin","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejps.2021.105961_bib0034","doi-asserted-by":"crossref","first-page":"5900","DOI":"10.1158\/0008-5472.CAN-17-1754","article-title":"KDM4 Inhibition Targets Breast Cancer Stem\u2013like Cells","volume":"77","author":"Metzger","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejps.2021.105961_bib0035","first-page":"77","article-title":"The comparison of the effects of panobinostat and PKF118-310 on \u03b2-catenin-dependent transcription in head and neck squamous cell carcinoma cell lines","volume":"77","author":"Paluszczak","year":"2020","journal-title":"Acta Pol. Pharm. - Drug Res."},{"key":"10.1016\/j.ejps.2021.105961_bib0036","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4161\/cbt.20846","article-title":"Preclinical modeling of EGFR inhibitor resistance in head and neck cancer","volume":"13","author":"Quesnelle","year":"2012","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejps.2021.105961_bib0037","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fonc.2019.00074","article-title":"Beyond EGFR Targeting in SCCHN: Angiogenesis, PI3K, and Other Molecular Targets","volume":"9","author":"Saada-Bouzid","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejps.2021.105961_bib0038","first-page":"6607","article-title":"GSKJ4, A Selective Jumonji H3K27 Demethylase Inhibitor, Effectively Targets Ovarian Cancer Stem Cells","volume":"35","author":"Sakaki","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejps.2021.105961_bib0039","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.taap.2013.07.013","article-title":"NOX4 mediates cytoprotective autophagy induced by the EGFR inhibitor erlotinib in head and neck cancer cells","volume":"272","author":"Sobhakumari","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105961_bib0040","doi-asserted-by":"crossref","first-page":"76087","DOI":"10.18632\/oncotarget.12590","article-title":"Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma","volume":"7","author":"Stanam","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejps.2021.105961_bib0041","doi-asserted-by":"crossref","first-page":"68591","DOI":"10.18632\/oncotarget.19793","article-title":"The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells","volume":"8","author":"Sui","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejps.2021.105961_bib0042","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.bios.2008.10.030","article-title":"In vitro study on the individual and synergistic cytotoxicity of adriamycin and selenium nanoparticles against Bel7402 cells with a quartz crystal microbalance","volume":"24","author":"Tan","year":"2009","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.ejps.2021.105961_bib0043","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.21873\/anticanres.11198","article-title":"Impact of H3K27 Demethylase Inhibitor GSKJ4 on NSCLC Cells Alone and in Combination with Metformin","volume":"36","author":"Watarai","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejps.2021.105961_bib0044","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.yexcr.2017.08.024","article-title":"GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells","volume":"359","author":"Yan","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejps.2021.105961_bib0045","doi-asserted-by":"crossref","first-page":"e12424","DOI":"10.1111\/cpr.12424","article-title":"Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma","volume":"51","author":"Zheng","year":"2018","journal-title":"Cell Prolif."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721002645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721002645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:58:13Z","timestamp":1760529493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721002645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":45,"alternative-id":["S0928098721002645"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105961","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inhibitors of KDM4 and KDM6 histone lysine demethylases enhance the anti-growth effects of erlotinib and HS-173 in head and neck cancer cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105961"}}